UDP-glucuronosyltransferase 1A4 (UGT1A4) polymorphisms in a Jordanian population

被引:14
作者
Hakooz, Nancy [1 ,2 ]
Alzubiedi, Sameh [2 ]
Yousef, Al-Motassem [2 ]
Arafat, Tawfiq [3 ]
Dajani, Rana [4 ]
Ababneh, Nidaa [5 ]
Ismail, Said [5 ]
机构
[1] Zarqa Univ, Fac Pharm, Zarqa 13132, Jordan
[2] Univ Jordan, Fac Pharm, Amman 11942, Jordan
[3] Jordan Ctr Pharmaceut Res, Amman 11195, Jordan
[4] Hashemite Univ, Dept Biol, Zarqa 13115, Jordan
[5] Univ Jordan, Fac Med, Amman 11942, Jordan
关键词
Drug metabolism; UGT1A4; Jordanian population; Polymorphism; CYP1A2 GENETIC POLYMORPHISMS; HUMAN LIVER-MICROSOMES; JAPANESE POPULATION; LEBANESE POPULATION; GLUCURONIDATION; PHARMACOGENETICS; TAMOXIFEN; PREVALENCE; TACROLIMUS; HAPLOTYPES;
D O I
10.1007/s11033-012-1615-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glucuronidation is one of the most important phase II metabolic pathways. It is catalyzed by a family of UDP-glucuronosyltransferase enzymes (UGTs). One of the subfamilies is UGT1A. Allele frequencies in UGT1A4 differ among ethnic groups. The aim of this study was to determine the allelic frequency of two most common defective alleles: UGT1A4*2 and UGT1A4*3 in a Jordanian population. A total of 216 healthy Jordanian Volunteers (165 males and 51 females) were included in this study. Genotyping for UGT1A4*1, UGT1A4*2 and UGT1A4*3 was done using a well established polymerase chain reaction-restriction fragment length polymorphism test. Among 216 random individuals studied for UGT1A4*2 mutation there were 26 individuals who were heterozygous, giving a prevalence of 12% and an allele frequency of 6.5%. Only one individual was homozygous for UGT1A4*2. The UGT1A4*3 mutation was detected as heterozygous in 9 of 216 individuals indicating a prevalence of 4.2% and allele frequency of 3.5%. Three individuals were homozygous for the UGT1A4*3 indicating a prevalence of 1.4%. The prevalence of UGT1A4*2 is similar to the Caucasians but different from other populations whilst the UGT1A4*3 prevalence in the Jordanian population is distinct from other populations. Our results provide useful information for the Jordanian population and for future genotyping of Arab populations in general.
引用
收藏
页码:7763 / 7768
页数:6
相关论文
共 50 条
  • [21] Inhibitory Effects of Commonly Used Herbal Extracts on UDP-Glucuronosyltransferase 1A4, 1A6, and 1A9 Enzyme Activities
    Mohamed, Mohamed-Eslam F.
    Frye, Reginald F.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (09) : 1522 - 1528
  • [22] Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men
    Karatzas, Anastasios
    Giannatou, Eirini
    Tzortzis, Vassilios
    Gravas, Stavros
    Aravantinos, Evangellos
    Moutzouris, George
    Melekos, Michael
    Tsezou, Aspasia
    CANCER EPIDEMIOLOGY, 2010, 34 (03) : 345 - 349
  • [23] Herbal Component Celastrol is an Inhibitor of UDP-Glucuronosyltransferase (UGT) 1A7
    Huang, Tao
    Jiang, Fen
    Mou, Xiao-Dong
    Zhang, Hai-Guang
    Ge, Jun-Bo
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (01): : 143 - 145
  • [24] Effect of Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 (UGT1A6) on Acetylsalicylic Acid Metabolism in Healthy Female Volunteers
    van Oijen, Martijn G. H.
    Barthelemy, Christine
    Janssen, Marcel J. R.
    Joiris, Etienne
    Peters, Wilbert H. M.
    Laheij, Robert J. F.
    Smits, Paul
    Odou, Pascal
    Jansen, Jan B. M. J.
    PHARMACOLOGY, 2009, 83 (04) : 237 - 242
  • [25] Identification of Human UDP-Glucuronosyltransferase 1A4 as the Major Isozyme Responsible for the Glucuronidation of 20(S)-Protopanaxadiol in Human Liver Microsomes
    Li, Jia
    He, Chunyong
    Fang, Lianxiang
    Yang, Li
    Wang, Zhengtao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03):
  • [26] Species difference in toxicokinetics and safety assessment of senecionine N-oxide in a UDP-glucuronosyltransferase 1A4 humanized mouse model
    Chen, Yan
    Tang, Yingying
    Liu, Pei
    Wang, Jinyuan
    Wang, Weiqian
    Wang, Changhong
    Ding, Lili
    Xiong, Aizhen
    Yang, Li
    Wang, Zhengtao
    CHEMICO-BIOLOGICAL INTERACTIONS, 2023, 380
  • [27] Function, Genetic Polymorphism, and Transcriptional Regulation of Human UDP-glucuronosyltransferase (UGT) 1A1
    Sugatani, Junko
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (02) : 83 - 92
  • [28] Interethnic Variations of UGT1A1 and UGT1A7 Polymorphisms in the Jordanian Population
    Abudahab, Sara
    Hakooz, Nancy
    Jarrar, Yazun
    Al Shhab, Mohammad
    Saleh, Ahmad
    Zihlif, Malek
    Dajani, Rana
    CURRENT DRUG METABOLISM, 2019, 20 (05) : 399 - 410
  • [29] TokyoGreen derivatives as specific and practical fluorescent probes for UDP-glucuronosyltransferase (UGT) 1A1
    Terai, Takuya
    Tomiyasu, Rie
    Ota, Tomoe
    Ueno, Tasuku
    Komatsu, Toru
    Hanaoka, Kenjiro
    Urano, Yasuteru
    Nagano, Tetsuo
    CHEMICAL COMMUNICATIONS, 2013, 49 (30) : 3101 - 3103
  • [30] Tacrolimus (Tacro) Strongly Inhibits Intestinal UDP-glucuronosyltransferase (UGT) 1A8
    Yu, Jian
    Wang, Chuan-Qiang
    Fang, Long-Hao
    Li, Meng
    Wang, Xiang-Yan
    Dai, Lu-Lu
    Gao, Ya-Jie
    LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (04): : 625 - 627